These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18388305)

  • 1. Concise review: adult multipotent stromal cells and cancer: risk or benefit?
    Lazennec G; Jorgensen C
    Stem Cells; 2008 Jun; 26(6):1387-94. PubMed ID: 18388305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on cancer related issues of mesenchymal stem cell-based therapies.
    Wang D; Wang S; Shi C
    Curr Stem Cell Res Ther; 2012 Sep; 7(5):370-80. PubMed ID: 22329585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?
    Bouffi C; Djouad F; Mathieu M; Noël D; Jorgensen C
    Rheumatology (Oxford); 2009 Oct; 48(10):1185-9. PubMed ID: 19561159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Specific Recruitment and Reprogramming of Mesenchymal Stem Cells in Tumorigenesis.
    Berger L; Shamai Y; Skorecki KL; Tzukerman M
    Stem Cells; 2016 Apr; 34(4):1011-26. PubMed ID: 26676563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy.
    Keung EZ; Nelson PJ; Conrad C
    Stem Cells; 2013 Feb; 31(2):227-35. PubMed ID: 23132810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trials With Mesenchymal Stem Cells: An Update.
    Squillaro T; Peluso G; Galderisi U
    Cell Transplant; 2016; 25(5):829-48. PubMed ID: 26423725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6.
    Lin JT; Wang JY; Chen MK; Chen HC; Chang TH; Su BW; Chang PJ
    Exp Cell Res; 2013 Aug; 319(14):2216-29. PubMed ID: 23751564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells: key players in cancer progression.
    Ridge SM; Sullivan FJ; Glynn SA
    Mol Cancer; 2017 Feb; 16(1):31. PubMed ID: 28148268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipotent mesenchymal stromal cells and immune tolerance.
    Noël D; Djouad F; Bouffi C; Mrugala D; Jorgensen C
    Leuk Lymphoma; 2007 Jul; 48(7):1283-9. PubMed ID: 17613755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifaceted role of mesenchymal stem cells in cancer.
    Timaner M; Tsai KK; Shaked Y
    Semin Cancer Biol; 2020 Feb; 60():225-237. PubMed ID: 31212021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling.
    Rodríguez R; García-Castro J; Trigueros C; García Arranz M; Menéndez P
    Adv Exp Med Biol; 2012; 741():187-205. PubMed ID: 22457111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
    Kanehira M; Fujiwara T; Nakajima S; Okitsu Y; Onishi Y; Fukuhara N; Ichinohasama R; Okada Y; Harigae H
    Stem Cells; 2017 Mar; 35(3):739-753. PubMed ID: 27641212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.
    Wu X; Jiang J; Gu Z; Zhang J; Chen Y; Liu X
    Stem Cell Res Ther; 2020 Aug; 11(1):345. PubMed ID: 32771052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking fusion of human mesenchymal stem cells after transplantation to the heart.
    Freeman BT; Kouris NA; Ogle BM
    Stem Cells Transl Med; 2015 Jun; 4(6):685-94. PubMed ID: 25848121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells from infants with simple polydactyly modulate immune responses more efficiently than adult mesenchymal stromal cells.
    Myneni VD; McClain-Caldwell I; Martin D; Vitale-Cross L; Marko K; Firriolo JM; Labow BI; Mezey E
    Cytotherapy; 2019 Feb; 21(2):148-161. PubMed ID: 30595353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.
    Sorrentino A; Ferracin M; Castelli G; Biffoni M; Tomaselli G; Baiocchi M; Fatica A; Negrini M; Peschle C; Valtieri M
    Exp Hematol; 2008 Aug; 36(8):1035-46. PubMed ID: 18504067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration.
    Dezawa M
    Cell Transplant; 2016; 25(5):849-61. PubMed ID: 26884346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
    Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
    Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.